Alternatively, ERβ2 is expressed in metastatic prostate cancer and its location in the nucleus correlates with decreased survival (29), increased invasiveness, cell proliferation, expression of Twist 1 and c-Myc in PC3 and 22Rv1 cells, thus indicating possible oncogenic roles of ERβ2 in PCa (30). Here, MYC is linked to posterior cortical atrophy.